Leadership & Pay ·
Helus Pharma appoints Dr. Suresh Durgam, former Intra-Cellular CMO, to its Board of Directors
CYBNCybin Inc.
Helus Pharma Inc. announced the appointment of Dr. Suresh Durgam to its Board of Directors. Dr. Durgam previously served on the company's Scientific Advisory Board and brings over two decades of experience in CNS drug development, regulatory strategy, and medical affairs. Most recently, he was Executive Vice President and Chief Medical Officer at Intra-Cellular Therapies, where he helped secure FDA approvals for CAPLYTA across multiple indications before the company's acquisition by Johnson & Johnson. His appointment is subject to approval by Cboe Canada. Helus Pharma Inc. is a clinical-stage pharmaceutical company developing novel serotonergic agonists for mental health conditions.